News Azzur Group Appoints New Leadership for Los Angeles Consulting Office Feb 22, 2023 Posted by Azzur of New England LLC
News Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP) Feb 22, 2023 Posted by FERRER INTERNACIONAL